CN104597246A - 基于核酸适体荧光探针HCy2的同型半胱氨酸试剂盒及其检测方法 - Google Patents
基于核酸适体荧光探针HCy2的同型半胱氨酸试剂盒及其检测方法 Download PDFInfo
- Publication number
- CN104597246A CN104597246A CN201410715996.4A CN201410715996A CN104597246A CN 104597246 A CN104597246 A CN 104597246A CN 201410715996 A CN201410715996 A CN 201410715996A CN 104597246 A CN104597246 A CN 104597246A
- Authority
- CN
- China
- Prior art keywords
- homocysteine
- nucleic acid
- fluorescence probe
- acid aptamer
- aptamer fluorescence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 title claims abstract description 138
- 239000000523 sample Substances 0.000 title claims abstract description 123
- 108091023037 Aptamer Proteins 0.000 title claims abstract description 26
- 238000001514 detection method Methods 0.000 title claims abstract description 22
- 210000004369 blood Anatomy 0.000 claims abstract description 40
- 239000008280 blood Substances 0.000 claims abstract description 40
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 30
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 22
- 238000005336 cracking Methods 0.000 claims abstract description 13
- 108091008104 nucleic acid aptamers Proteins 0.000 claims description 63
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 claims description 42
- 230000005284 excitation Effects 0.000 claims description 30
- 238000012360 testing method Methods 0.000 claims description 26
- 102000002322 Egg Proteins Human genes 0.000 claims description 23
- 108010000912 Egg Proteins Proteins 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 23
- 210000004681 ovum Anatomy 0.000 claims description 23
- 239000012530 fluid Substances 0.000 claims description 22
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 claims description 21
- 239000008363 phosphate buffer Substances 0.000 claims description 19
- 238000002156 mixing Methods 0.000 claims description 15
- 239000007983 Tris buffer Substances 0.000 claims description 14
- 239000000178 monomer Substances 0.000 claims description 14
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 14
- 239000006228 supernatant Substances 0.000 claims description 13
- 239000000539 dimer Substances 0.000 claims description 11
- 210000005259 peripheral blood Anatomy 0.000 claims description 11
- 239000011886 peripheral blood Substances 0.000 claims description 11
- 230000005477 standard model Effects 0.000 claims description 11
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 10
- 239000003146 anticoagulant agent Substances 0.000 claims description 10
- 229940127219 anticoagulant drug Drugs 0.000 claims description 10
- 230000005281 excited state Effects 0.000 claims description 10
- 229960002897 heparin Drugs 0.000 claims description 10
- 229920000669 heparin Polymers 0.000 claims description 10
- 239000002773 nucleotide Substances 0.000 claims description 9
- 125000003729 nucleotide group Chemical group 0.000 claims description 9
- 230000008859 change Effects 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 238000001685 time-resolved fluorescence spectroscopy Methods 0.000 claims description 2
- 210000003743 erythrocyte Anatomy 0.000 abstract description 10
- 239000000126 substance Substances 0.000 abstract description 3
- 239000007850 fluorescent dye Substances 0.000 abstract description 2
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 230000035558 fertility Effects 0.000 abstract 1
- 239000006166 lysate Substances 0.000 abstract 1
- 239000008055 phosphate buffer solution Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 238000004108 freeze drying Methods 0.000 description 9
- 229910021642 ultra pure water Inorganic materials 0.000 description 9
- 239000012498 ultrapure water Substances 0.000 description 9
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000013077 target material Substances 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- QEDXSHCYPROEOK-UHFFFAOYSA-N 3-phosphanylpropanoic acid Chemical class OC(=O)CCP QEDXSHCYPROEOK-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 108091027568 Single-stranded nucleotide Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002875 fluorescence polarization Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 201000010193 neural tube defect Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 208000035581 susceptibility to neural tube defects Diseases 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6402—Atomic fluorescence; Laser induced fluorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biotechnology (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410715996.4A CN104597246B (zh) | 2014-11-30 | 2014-11-30 | 基于核酸适体荧光探针HCy2的同型半胱氨酸试剂盒及其检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410715996.4A CN104597246B (zh) | 2014-11-30 | 2014-11-30 | 基于核酸适体荧光探针HCy2的同型半胱氨酸试剂盒及其检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104597246A true CN104597246A (zh) | 2015-05-06 |
CN104597246B CN104597246B (zh) | 2016-06-15 |
Family
ID=53123165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410715996.4A Expired - Fee Related CN104597246B (zh) | 2014-11-30 | 2014-11-30 | 基于核酸适体荧光探针HCy2的同型半胱氨酸试剂盒及其检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104597246B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105606582A (zh) * | 2016-03-25 | 2016-05-25 | 徐大鹏 | 基于核酸适体荧光探针afp4的甲胎蛋白试剂盒及其检测方法 |
CN105651754A (zh) * | 2016-03-25 | 2016-06-08 | 徐大鹏 | 基于核酸适体荧光探针afp2的甲胎蛋白试剂盒及其检测方法 |
CN105651755A (zh) * | 2016-03-25 | 2016-06-08 | 徐大鹏 | 基于核酸适体荧光探针afp1的甲胎蛋白试剂盒及其检测方法 |
CN105785034A (zh) * | 2016-03-25 | 2016-07-20 | 徐大鹏 | 基于核酸适体荧光探针afp3的甲胎蛋白试剂盒及其检测方法 |
CN105785033A (zh) * | 2016-03-25 | 2016-07-20 | 徐大鹏 | 基于核酸适体荧光探针afp5的甲胎蛋白试剂盒及其检测方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107941767A (zh) * | 2017-11-23 | 2018-04-20 | 王颖皓 | 基于核酸适体荧光探针gsh2的谷胱甘肽试剂盒及其检测方法 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008150873A1 (en) * | 2007-05-31 | 2008-12-11 | Purdue Research Foundation | Ultrasensitive detection of biomolecules using immunoseparation and diffractometry |
CN101458215A (zh) * | 2008-09-03 | 2009-06-17 | 中国科学院长春应用化学研究所 | 一种多联吡啶钌络合物的电化学发光适配子传感器及制法 |
CN102165071A (zh) * | 2008-02-21 | 2011-08-24 | Otc生物技术有限公司 | 制备均质塑料-粘附适体-磁珠-荧光团和其他夹心分析物的方法 |
US20120219961A1 (en) * | 2006-05-12 | 2012-08-30 | Pronucleotein Biotechnologies, Llc | Methods of running assays using intrachain fluorophore-quencher FRET-aptamers |
CN104568867A (zh) * | 2014-11-30 | 2015-04-29 | 陈燕婷 | 基于核酸适体荧光探针HCy1的同型半胱氨酸试剂盒及其检测方法 |
CN104561009A (zh) * | 2014-11-30 | 2015-04-29 | 陈燕婷 | 同型半胱氨酸核酸适体HCy2及其制备方法 |
CN104597008A (zh) * | 2014-11-30 | 2015-05-06 | 陈燕婷 | 基于核酸适体荧光探针HCy3的同型半胱氨酸试剂盒及其检测方法 |
CN104597007A (zh) * | 2014-11-30 | 2015-05-06 | 陈燕婷 | 基于核酸适体荧光探针HCy5的同型半胱氨酸试剂盒及其检测方法 |
CN104677868A (zh) * | 2014-11-30 | 2015-06-03 | 陈燕婷 | 基于核酸适体荧光探针HCy4的同型半胱氨酸试剂盒及其检测方法 |
-
2014
- 2014-11-30 CN CN201410715996.4A patent/CN104597246B/zh not_active Expired - Fee Related
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120219961A1 (en) * | 2006-05-12 | 2012-08-30 | Pronucleotein Biotechnologies, Llc | Methods of running assays using intrachain fluorophore-quencher FRET-aptamers |
WO2008150873A1 (en) * | 2007-05-31 | 2008-12-11 | Purdue Research Foundation | Ultrasensitive detection of biomolecules using immunoseparation and diffractometry |
CN102165071A (zh) * | 2008-02-21 | 2011-08-24 | Otc生物技术有限公司 | 制备均质塑料-粘附适体-磁珠-荧光团和其他夹心分析物的方法 |
CN101458215A (zh) * | 2008-09-03 | 2009-06-17 | 中国科学院长春应用化学研究所 | 一种多联吡啶钌络合物的电化学发光适配子传感器及制法 |
CN104568867A (zh) * | 2014-11-30 | 2015-04-29 | 陈燕婷 | 基于核酸适体荧光探针HCy1的同型半胱氨酸试剂盒及其检测方法 |
CN104561009A (zh) * | 2014-11-30 | 2015-04-29 | 陈燕婷 | 同型半胱氨酸核酸适体HCy2及其制备方法 |
CN104597008A (zh) * | 2014-11-30 | 2015-05-06 | 陈燕婷 | 基于核酸适体荧光探针HCy3的同型半胱氨酸试剂盒及其检测方法 |
CN104597007A (zh) * | 2014-11-30 | 2015-05-06 | 陈燕婷 | 基于核酸适体荧光探针HCy5的同型半胱氨酸试剂盒及其检测方法 |
CN104677868A (zh) * | 2014-11-30 | 2015-06-03 | 陈燕婷 | 基于核酸适体荧光探针HCy4的同型半胱氨酸试剂盒及其检测方法 |
Non-Patent Citations (3)
Title |
---|
MAUREEN MCKEAGUE ET AL: "Development of a DNA aptamer for direct and selective homocysteine detection in human serum", 《RSC ADVANCES》 * |
张秀梅等: "血浆与血清同型半胱氨酸在不同检测条件下比较及稳定性研究", 《中国实验诊断学》 * |
杨绍明等: "半胱氨酸封闭剂为电化学探针的非标记型核酸适配体传感器", 《应用化学》 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105606582A (zh) * | 2016-03-25 | 2016-05-25 | 徐大鹏 | 基于核酸适体荧光探针afp4的甲胎蛋白试剂盒及其检测方法 |
CN105651754A (zh) * | 2016-03-25 | 2016-06-08 | 徐大鹏 | 基于核酸适体荧光探针afp2的甲胎蛋白试剂盒及其检测方法 |
CN105651755A (zh) * | 2016-03-25 | 2016-06-08 | 徐大鹏 | 基于核酸适体荧光探针afp1的甲胎蛋白试剂盒及其检测方法 |
CN105785034A (zh) * | 2016-03-25 | 2016-07-20 | 徐大鹏 | 基于核酸适体荧光探针afp3的甲胎蛋白试剂盒及其检测方法 |
CN105785033A (zh) * | 2016-03-25 | 2016-07-20 | 徐大鹏 | 基于核酸适体荧光探针afp5的甲胎蛋白试剂盒及其检测方法 |
CN105785034B (zh) * | 2016-03-25 | 2017-10-20 | 广州大学城健康产业科技园投资管理有限公司 | 基于核酸适体荧光探针afp3的甲胎蛋白试剂盒及其检测方法 |
CN107561285A (zh) * | 2016-03-25 | 2018-01-09 | 蒋志超 | 一种高效甲胎蛋白试剂盒 |
CN107561284A (zh) * | 2016-03-25 | 2018-01-09 | 蒋志超 | 易于操作的甲胎蛋白试剂盒 |
CN107561286A (zh) * | 2016-03-25 | 2018-01-09 | 张少华 | 一种高灵敏度的甲胎蛋白试剂盒 |
CN107576801A (zh) * | 2016-03-25 | 2018-01-12 | 张少华 | 一种基于核酸适体荧光探针afp5的甲胎蛋白试剂盒 |
CN107561285B (zh) * | 2016-03-25 | 2019-03-22 | 上海宝藤生物医药科技股份有限公司 | 一种基于核酸适体荧光探针afp5的甲胎蛋白试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN104597246B (zh) | 2016-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104597246B (zh) | 基于核酸适体荧光探针HCy2的同型半胱氨酸试剂盒及其检测方法 | |
ES2553456T3 (es) | Perfilado de proteínas de ruta de señal para determinar una eficacia terapéutica | |
Chen et al. | G-quadruplex-based detection of glyphosate in complex biological systems by a time-resolved luminescent assay | |
CN105044055B (zh) | 一种蛋白质的检测方法及蛋白质检测阵列传感器 | |
Finete et al. | Characterization of newfound natural luminescent properties of melamine, and development and validation of a method of high performance liquid chromatography with fluorescence detection for its determination in kitchen plastic ware | |
CN110044855A (zh) | 双受体时间分辨时间分辨荧光共振能量转移法 | |
Guo et al. | Direct visualization of sub-femtomolar circulating microRNAs in serum based on the duplex-specific nuclease-amplified oriented assembly of gold nanoparticle dimers | |
CN104597007B (zh) | 基于核酸适体荧光探针HCy5的同型半胱氨酸试剂盒及其检测方法 | |
Jeber et al. | An optoelectronic flow-through detectors for active ingredients determination in the pharmaceutical formulations | |
CN104597008B (zh) | 基于核酸适体荧光探针HCy3的同型半胱氨酸试剂盒及其检测方法 | |
CN104677868A (zh) | 基于核酸适体荧光探针HCy4的同型半胱氨酸试剂盒及其检测方法 | |
CN105606582A (zh) | 基于核酸适体荧光探针afp4的甲胎蛋白试剂盒及其检测方法 | |
CN104568867A (zh) | 基于核酸适体荧光探针HCy1的同型半胱氨酸试剂盒及其检测方法 | |
CN104046682B (zh) | 同型半胱氨酸的检测方法及其诊断试剂盒 | |
CN105785034B (zh) | 基于核酸适体荧光探针afp3的甲胎蛋白试剂盒及其检测方法 | |
CN105785033B (zh) | 基于核酸适体荧光探针afp5的甲胎蛋白试剂盒及其检测方法 | |
CN104569374A (zh) | 一种快速定量检测c-反应蛋白的均相荧光免疫试剂组及其制备方法 | |
CN107907515A (zh) | 一种检测谷胱甘肽探针试剂盒及其检测方法 | |
CN102998289B (zh) | 基于核酸适体荧光探针的糖化血红蛋白试剂盒及其检测方法 | |
CN107941766A (zh) | 利用核酸适体荧光探针测定谷胱甘肽试剂盒及其检测方法 | |
CN105755097B (zh) | 全面筛选青黛中抗白血病活性成分及确定其靶标的方法 | |
CN107941767A (zh) | 基于核酸适体荧光探针gsh2的谷胱甘肽试剂盒及其检测方法 | |
CN106645053A (zh) | 基于高灵敏度核酸适体荧光探针ins3胰岛素试剂盒及其检测方法 | |
CN105651755A (zh) | 基于核酸适体荧光探针afp1的甲胎蛋白试剂盒及其检测方法 | |
CN105651754A (zh) | 基于核酸适体荧光探针afp2的甲胎蛋白试剂盒及其检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Jiahua Inventor before: Chen Yanting Inventor before: Zhang Shenman Inventor before: Li Hongmei |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160510 Address after: Department of laboratory in Shandong province Binzhou city 256600 hospital Binnan Bincheng District the Yellow River six road No. 531, Shengli Petroleum Administration Bureau Applicant after: Li Jiahua Address before: 530022 Nanning National Road, the Guangxi Zhuang Autonomous Region, No. 89 Applicant before: Chen Yanting Applicant before: Zhang Shenman Applicant before: Li Hongmei |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Yanfang Inventor before: Li Jiahua |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171009 Address after: 330114 Jiangxi city of Nanchang province Xinjian County Lehua Town Village bear home natural Village No. 10 Patentee after: Liu Yanfang Address before: Department of laboratory in Shandong province Binzhou city 256600 hospital Binnan Bincheng District the Yellow River six road No. 531, Shengli Petroleum Administration Bureau Patentee before: Li Jiahua |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180119 Address after: Longhua street Longhua District Guangdong city Shenzhen province 518000 Dragon Dragon Technology Park Hong Qing Technology Incubation Center 4 area I Patentee after: Shenzhen a biotech Co., Ltd. Address before: 330114 Jiangxi city of Nanchang province Xinjian County Lehua Town Village bear home natural Village No. 10 Patentee before: Liu Yanfang |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160615 Termination date: 20191130 |